The Global Market for Blood Gas & Electrolyte Analyzers is Projected to Reach 32 Thousand Units Worth US$568 Million by 2020
Increasing Demand in Critical
Care Drives the Global Blood Gas and Electrolyte Analyzers Market, According to
a New Report by Global Industry Analysts, Inc.
GIA
launches comprehensive analysis of industry segments, trends, growth drivers,
market share, size and demand forecasts on the global Blood Gas &
Electrolyte Analyzers market. The global market for Blood
Gas & Electrolyte Analyzers is projected to reach 32 thousand units worth
US$568 million by 2020, driven by technological advancements in point-of-care devices and
integrated, multi-parameter measuring devices for use in ICU and ER
applications.
Blood
Gas and Electrolyte or Blood Gas Analyzers (BGA) measure the concentration of
oxygen, CO2, electrolytes, pH of blood,
and other parameters which are crucial indicators of shock, hemorrhage, drug
overdose, or pulmonary disorders. Blood gas & electrolyte analyzers are
thus vital for Emergency Room and ICU applications. The market is mainly
characterized by a paradigm shift from central laboratory based devices to
point-of-care devices. BGA manufacturers are increasingly focused on developing
user-friendly, automated devices that save time and provide highly accurate
results and measurements which are vital in critical care applications. Innovations
coupled with smart engineering are helping redefine opportunities in the market.
Miniaturization is an important technology trend with manufacturers focusing on
the development of compact, advanced, sleek, handheld instruments.
Newer features
of POC analyzers include integrated quality controls, extended menus,
programmable settings, and symbols and touchscreens to ensure user
friendliness. Devices with automated testing abilities are sought after in
high-volume applications in critical care.
The
market is also driven by the growing geriatric population and its
susceptibility to chronic end-of-life diseases. These factors result in increased
hospital admissions and demand for health parameter-monitoring devices. Despite
the opportunities for growth, penetration of POC devices in critical care is
restrained by high costs of devices and a complicated regulatory framework for
medical devices. Combined blood gas and electrolyte analyzers are gaining
prominence over standalone electrolyte analyzers, due to their ability to
measure blood gases as well as electrolytes from a single sample of blood,
plasma, serum, or urine. While blood gas analysis remains one of the most
preferred patient monitoring systems, a trend of combining blood gas analysis
and pulse oximetry, is gaining popularity. Most of the current instrumentations
are coming with the ability to integrate with EMRs, vastly improving workflow
at medical and healthcare facilities.
As
stated by the new market research report on Blood Gas and Electrolyte
Analyzers, the
United States represents the single largest market worldwide, supported by the high
number of patients treated annually at hospitals. Asia-Pacific ranks as the
fastest growing market both in terms of value and volume with estimated compounded
annual growth rates of 7.2% and 6.5% respectively over the analysis period. Blood
Gas Analyzers represent the leading segment, led by benchtop analyzers with a 66.3%
share of value sales in 2015. Point-of-care analyzers, accounting for 31.3%, represent
the fastest growing segment with a projected CAGR of 5.9%.
Major
players covered in the report include Abaxis Inc., Abbott Point-of-Care Inc., Alere
Inc., Beckman Coulter Inc., Hemagen Diagnostics Inc., IDEXX Laboratories Inc., OPTI
Medical Systems, Inc., Instrumentation Laboratory, Medica Corporation, Nova
Biomedical Corporation, Radiometer A/S, Roche Diagnostics Ltd., and Siemens
Healthcare GmbH, among others.
The research report titled “Blood Gas & Electrolyte
Analyzers: A Global Strategic Business Report” announced by Global Industry Analysts Inc.,
provides a comprehensive review
of the market trends, market issues, growth drivers, and strategic industry
activity of global companies. The report
provides market estimates and projections for major geographic markets,
including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia,
and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific),
Latin America (Brazil, and Rest of Latin America), and Rest of World. Product
types analyzed include Blood Gas Analyzers (Benchtop Analyzers and
Point-of-Care Analyzers) and Electrolyte Analyzers.
Global Industry Analysts, Inc. 6150 Hellyer
Ave., San Jose CA 95138, USA, All Rights Reserved.
Comments
Post a Comment